Elite Pharmaceuticals Inc. (OTCMKTS:ELTP – Get Free Report)’s share price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.57 and traded as low as $0.4615. Elite Pharmaceuticals shares last traded at $0.4695, with a volume of 974,491 shares trading hands.
Elite Pharmaceuticals Stock Down 1.2%
The firm has a market cap of $505.65 million, a price-to-earnings ratio of 47.00 and a beta of 0.32. The firm has a 50 day moving average of $0.52 and a 200 day moving average of $0.57. The company has a quick ratio of 6.34, a current ratio of 8.04 and a debt-to-equity ratio of 0.06.
Elite Pharmaceuticals Company Profile
Elite Pharmaceuticals, Inc is a U.S.-based specialty pharmaceutical company that acquires, develops and markets both branded and generic pharmaceutical products. Headquartered in Houston, Texas, the company focuses on complex dosage forms—including injectables, sterile formulations and oncology therapies—and seeks to address unmet medical needs through advanced drug delivery technologies. Its product portfolio spans therapeutic areas such as pain management, oncology and cardiovascular care.
Since its founding in 2007, Elite Pharmaceuticals has pursued strategic partnerships and licensing agreements to expand its pipeline and manufacturing capabilities.
Recommended Stories
- Five stocks we like better than Elite Pharmaceuticals
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
